Related references
Note: Only part of the references are listed.
Article
Hematology
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
Bruce D. Cheson et al.
BLOOD (2006)
Article
Oncology
Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy?
G Visani et al.
LEUKEMIA & LYMPHOMA (2004)
Article
Hematology
Low dose melphalan is a treatment option in elderly patients with high risk myelodysplastic syndrome or secondary acute myeloblastic leukaemia
K Anargyrou et al.
HAEMATOLOGIA (2002)
Share Paper
